Viatris Inc (VTRS) Stock Analysis

Viatris Inc (VTRS) is a publicly traded company in the HEALTHCARE sector. It trades at $15.69, carries a market capitalization of $18.94B, a dividend yield of 0.03%. This page summarizes the public market data, fundamentals, and frequently asked questions for VTRS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $15.69
• Market Cap: $18.94B
• EPS: $-0.30
• Dividend Yield: 0.03%
• 52-Week High: $17.40
• 52-Week Low: $8.12

Market Sentiment

Viatris Inc currently has a Neutral sentiment score of 0.11.

About Viatris Inc

Viatris Inc. (VTRS) is a prominent global healthcare company headquartered in Canonsburg, Pennsylvania, formed through the strategic merger of Mylan and Upjohn, a division of Pfizer. With a comprehensive portfolio that encompasses generic, branded, and over-the-counter medications, Viatris is dedicated to expanding access to high-quality medicines across more than 165 countries. The company focuses on addressing diverse health challenges and improving patient outcomes through its extensive di...

GNG Research Analysis

GNG Research scores Viatris Inc (VTRS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VTRS.

Frequently Asked Questions

What is VTRS's current dividend yield?

Viatris Inc (VTRS) has a current dividend yield of 0.03%.

Does VTRS pay dividends?

Yes, Viatris Inc pays dividends with a current yield of 0.03%.

What is VTRS's market cap?

Viatris Inc (VTRS) has a market capitalization of $18.94B with a current stock price of $15.69.